Prosecution Insights
Prosecution Insights
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (17%) |
| §103 only | 2 (33%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALLEN, MICHAEL D | 1 | 32.4% | +49.2% |
| MEYERING, SHABANA SHABBEER | 1 | 69.7% | +41.8% |
| VANHORN, ABIGAIL LOUISE | 1 | 47.0% | +22.0% |
| CRUM, MARY ABOU NADER | 1 | 40.9% | +65.0% |
| SCHACHERMEYER, SAMANTHA LYNN | 1 | 36.1% | +70.8% |
| DACE DENITO, ALEXANDRA GERALDINE | 1 | 60.3% | +35.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18001571 | UNA OLIGOMERS FOR THE TREATMENT OF POLYGLUTAMINE DISEASES | VANHORN, ABIGAIL LOUISE | 43d overdue |
| 17311271 | MODIFIED PROTEINS AND ASSOCIATED METHODS OF TREATMENT | DACE DENITO, ALEXANDRA GERALDINE | 70d |
| 18427625 | METHODS AND COMPOSITIONS FOR QUADRIVALENT INFLUENZA VACCINE | ALLEN, MICHAEL D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18001571 | UNA OLIGOMERS FOR THE TREATMENT OF POLYGLUTAMINE DISEASES | VANHORN, ABIGAIL LOUISE | 43d overdue |
| 17311271 | MODIFIED PROTEINS AND ASSOCIATED METHODS OF TREATMENT | DACE DENITO, ALEXANDRA GERALDINE | 70d |
| 18427625 | METHODS AND COMPOSITIONS FOR QUADRIVALENT INFLUENZA VACCINE | ALLEN, MICHAEL D | — |
| 18345379 | METHODS FOR IN VITRO TRANSCRIPTION | MEYERING, SHABANA SHABBEER | — |
| 17737884 | LIPID COMPOSITIONS COMPRISING PEPTIDE-LIPID CONJUGATES | CRUM, MARY ABOU NADER | — |
| 17619882 | IMPROVED IN VITRO TRANSCRIPTION PURIFICATION PLATFORM | SCHACHERMEYER, SAMANTHA LYNN | — |
| Art Unit | Apps |
|---|---|
| 1636 | 2 |
| 1671 | 1 |
| 1635 | 1 |
| 1657 | 1 |
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18427625 | METHODS AND COMPOSITIONS FOR QUADRIVALENT INFLUENZA VACCINE | ALLEN, MICHAEL D | 1671 | §101§102§103§112 | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18345379 | METHODS FOR IN VITRO TRANSCRIPTION | MEYERING, SHABANA SHABBEER | 1635 | §103 | Final Rejection | — | Pending | Jun 30, 2023 |
| 18001571 | UNA OLIGOMERS FOR THE TREATMENT OF POLYGLUTAMINE DISEASES | VANHORN, ABIGAIL LOUISE | 1636 | §103§112Other | Non-Final OA | 43d overdue | Pending | Dec 12, 2022 |
| 17737884 | LIPID COMPOSITIONS COMPRISING PEPTIDE-LIPID CONJUGATES | CRUM, MARY ABOU NADER | 1657 | §102§103§112DP | Non-Final OA | — | Pending | May 05, 2022 |
| 17619882 | IMPROVED IN VITRO TRANSCRIPTION PURIFICATION PLATFORM | SCHACHERMEYER, SAMANTHA LYNN | 1693 | §103 | Non-Final OA | — | Pending | Dec 16, 2021 |
| 17311271 | MODIFIED PROTEINS AND ASSOCIATED METHODS OF TREATMENT | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §103§112 | Final Rejection | 70d | Pending | Jun 04, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial